Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4433 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GenData and Amgen announce genetics pact

The terms of the collaboration include sponsored research activities, product development milestones, and financial consideration associated with therapeutic and diagnostic products that result from the collaboration. Detailed financial

Acambis smallpox vaccine fast-tracked

Acambis has delivered 182.5 million doses of ACAM2000 to the US Government for its emergency-use Strategic National Stockpile and has orders from several other governments around the world

Genaera eye drug selected for FDA program

Participation in the Pilot 2 program is limited to no more than one fast track product for each review division within the Center for Drug Evaluation and Research

VaxGen restructures Celltrion agreements

In February 2002, VaxGen and a group of South Korean investors formed Celltrion, a South Korean joint venture, to establish a large-scale biopharmaceutical manufacturing business in South Korea.

H3 Pharma gets approvable letter for Sanvar

In the letter, the FDA requests additional supportive efficacy data on the product candidate and additional information related to manufacturing aspects of the product. H3 Pharma intends to